Please Wait...

Beatriz Lega

Translation skills

Main profile

Beatriz L. Lega, M.D.
Medical Oncologist

Dr. Lega received her MD degree from the Medical School of the National University of Cordoba, Argentina. She completed her internship and residency in Internal Medicine at Mountainside Hospital and at UMDNJ-Rutgers Medical School (now Robert Wood Johnson) and completed her fellowships in Oncology and Hematology at Rhode Island Hospital (Brown University) and Rutgers Medical School. She teaches at both the Drexel University College of Medicine and the Robert Wood Johnson Medical School where she is a Clinical Professor of Internal Medicine.

Prior to joining BioClinica (formerly CoreLab Partners) in 2007, Dr. Lega has been in practice in the Hematology-Oncology Department at Saint Peter’s University Hospital and the Garden State Medical Group/HIP of New Jersey where she developed an out-patient chemotherapy treatment and transfusion unit and became chief of the Internal Medicine and Oncology Divisions. Dr. Lega was also on staff at the Oncology unit at Rhode Island Medical Center. For many years she served as a member in the Cancer Committees at Robert Wood Johnson University Hospital and at Saint Peter’s University Hospital, where she was Tumor Board Moderator and Chair of the Cancer Committee.
 
Dr. Lega is board certified in Internal Medicine, Medical Oncology and Hematology, and a member of the American Society of Clinical Oncology and the American Society of Hematology.
 
With more than 20 years of clinical practice in Medical Oncology, Dr. Lega main research and clinical interests has been the prevention and treatment of breast cancer. She has been an investigator for many years in NSABP clinical trials and has participated in CALGB, ECOG and multiple industry-sponsored clinical trials and is registered with the National Cancer Institute as an independent investigator. She has presented on prostate cancer and written on bladder involvement in metastatic breast cancer.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

In our latest blog post, we review the "burdens" of #CTMS implementation - and how better solutions address them.… https://t.co/vcyS2gvwpu
Bioclinica (2 days ago)
David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/01liAxqx0J
Bioclinica (3 days ago)
Rapid implementation. Increased control & efficiency. Out-of-the-box configuration. Turn-key validation. Cost savin… https://t.co/XO53jwd2DV
Bioclinica (2 weeks ago)
David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/ZtxVWMlznP
Bioclinica (2 weeks ago)
Bioclinica's #IRT uses an agile delivery methodology, which means flexible configuration and customization, and del… https://t.co/SRd2uNscWc
Bioclinica (2 weeks ago)
Presenting Bioclinica CTMS: a rapid startup #CTMS that takes 2 weeks to implement, rather than months. Bioclinica C… https://t.co/9IH38ix6nW
Bioclinica (3 weeks ago)